Fig. 1From: Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in GermanyModel structure, adopted from [16, 17]. Transitions to the “Death” state are possible from every state, but not shown on the diagram for better clarity. MDR-TB: Multidrug resistant tuberculosis; TB: tuberculosisBack to article page